Investment Rating - The investment rating for the company is "Add" (maintained) [6] Core Views - The company achieved a revenue of 1.56 billion yuan in 2024, representing a year-on-year increase of 13.4%, and a net profit of 160 million yuan, up 14.1% year-on-year [1] - The adult toothpaste segment showed excellent growth, with revenue increasing by 16.1%, while the e-commerce channel remains the core driver of the company's growth [2] - The optimization of product structure has significantly boosted the gross margin, which reached 49.37% in 2024, up 5.3 percentage points year-on-year [3] Financial Performance - In 2024, the company reported a net cash flow from operating activities of 181 million yuan, a year-on-year increase of 20.1% [4] - The company's gross margin for adult toothpaste was 50.47%, reflecting a 5.5 percentage point increase year-on-year [3] - The company’s net profit margin for 2024 was 10.33%, a slight increase of 0.06 percentage points year-on-year [3] Market Position - The company has maintained a steady increase in market share, ranking third in the offline retail channel for toothpaste products, and second among domestic brands [5] - The "Cold Acid Spirit" brand has seen its market share in the sensitive toothpaste segment increase from 61.74% in 2022 to 64.72% in 2024 [5] Earnings Forecast - The company is expected to achieve revenues of 1.87 billion yuan, 2.27 billion yuan, and 2.80 billion yuan in 2025, 2026, and 2027, respectively, with year-on-year growth rates of 19.65%, 21.73%, and 23.21% [10] - The forecasted net profit for 2025 is 196 million yuan, representing a year-on-year growth of 21.75% [10]

Core Viewpoint - The company reported a revenue of 1.56 billion yuan for 2024, representing a year-over-year increase of 13.4%, and a net profit attributable to shareholders of 160 million yuan, up 14.1% year-over-year, meeting expectations [1] Financial Performance - For Q4 2024, the company achieved a revenue of 510 million yuan, a year-over-year increase of 39.1%, with a net profit of 40 million yuan, up 28.6% year-over-year [1] - In Q1 2025, the company reported a revenue of 430 million yuan, a year-over-year increase of 19.4%, with a net profit of 40 million yuan, up 15.6% year-over-year [1] Product Category Performance - Adult toothpaste revenue reached 1.25 billion yuan, a year-over-year increase of 16.1%, with H1 and H2 growth rates of 7.0% and 24.4% respectively [2] - Adult toothbrush revenue was 160 million yuan, a year-over-year increase of 3.3%, with H1 and H2 growth rates of 0.6% and 6.1% respectively [2] - Oral medical and beauty care products generated 40 million yuan in revenue, a year-over-year increase of 35.5%, with H1 and H2 growth rates of -10.5% and +87.6% respectively [2] - Children's toothpaste and toothbrush revenues were relatively weak, at 70 million yuan and 30 million yuan respectively, with year-over-year changes of -0.5% and -5.1% [2] Sales Model Analysis - The distribution model generated 1.03 billion yuan in revenue, a year-over-year increase of 3.7%, accounting for 66% of total revenue [3] - The e-commerce model saw revenue of 480 million yuan, a year-over-year increase of 52.0%, accounting for 31% of total revenue [3] - The direct supply model reported revenue of 40 million yuan, a year-over-year decrease of 24.0% [3] Margin and Cost Analysis - The gross margin was 50.5%, an increase of 5.5 percentage points year-over-year, with H1 and H2 margins at 48.1% and 52.3% respectively [2] - The company’s gross margin, period expense ratio, and net profit margin for 2024 were 49.4%, 39.1%, and 10.3% respectively, showing year-over-year increases [3] Investment Outlook - The company is expected to continue benefiting from high-priced differentiated products driving e-commerce growth, which may enhance the willingness of offline distributors to stock higher-margin products [4] - Projected net profits for 2025-2027 are 210 million yuan, 240 million yuan, and 260 million yuan respectively, with year-over-year growth rates of 27.2%, 16.5%, and 10.5% [4]

重庆登康口腔护理用品股份有限公司 关于举办2024年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重庆登康口腔护理用品股份有限公司（以下简称"公司"）已于2025年4月22日在 巨潮资讯网上披露了《2024年年度报告》全文及其摘要。为便于广大投资者更加全面 深入地了解公司经营业绩、发展战略等情况，公司定于2025年4月25日（星期五） 15:00～16:00在"价值在线"（www.ir-online.cn）举办2024年度网上业绩说明会，与投 资者进行沟通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 证券代码：001328 证券简称：登康口腔 公告编号：2025-022 注：如遇特殊情况，参会人员可能进行调整。 三、投资者参与方式 投 资 者 可 于 2025 年 4 月 25 日 （ 星 期 五 ） 15:00 ～ 16:00 通过网址 https://eseb.cn/1nFZWtTueEU或使用微信扫描下方小程序码参与互动交流，公司将在信 息披露允许范围内就投资者普遍关注的问题进行回答。 为提升交流的针对 ...

Investment Rating - The report upgrades the company to a "Buy" rating, reflecting a positive outlook for the next 6-12 months with expected price increases [3]. Core Insights - The company reported a revenue of 1.56 billion RMB for 2024, representing a year-on-year growth of 13.4%, and a net profit of 161 million RMB, up 14.07% year-on-year [2]. - The growth is driven by the successful launch of high-demand products, particularly in the sensitive teeth segment, and effective marketing strategies leveraging platforms like Douyin [3][2]. - The company is positioned as a leader in the sensitive oral care niche, with a significant market share in various product categories [3]. Performance Analysis - For 2024, the revenue breakdown by product includes adult toothpaste (1.247 billion RMB), adult toothbrushes (161 million RMB), children's toothpaste (72 million RMB), and electric toothbrushes (10 million RMB), with notable growth in sensitive care products [2]. - The revenue from different channels shows a significant increase in e-commerce sales by 51.99%, while direct supply and distribution channels experienced declines [2]. - The gross margin for 2024 is reported at 49.37%, an increase of 5.27 percentage points year-on-year, driven by the introduction of high-end products [3]. Financial Projections - The company is projected to achieve net profits of 200 million RMB, 258 million RMB, and 332 million RMB for the years 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 38.48, 29.78, and 23.17 [3][7]. - The expected revenue growth rates for the upcoming years are 27.91% for 2025, 20.88% for 2026, and 18.20% for 2027, indicating a strong growth trajectory [7]. Market Position - The company ranks third in retail sales market share for toothpaste in offline channels, and its children's toothpaste and toothbrushes are positioned third and first in their respective categories [2]. - The report highlights the company's ability to leverage social media marketing to enhance brand visibility and drive sales growth [3].

产品结构升级推升单价、毛利率提升。24 年毛利率 49.37%（同比 +5.27pct），修护系列高端爆品带动毛利率向上提振，2024 年销售 费用率为 31.96%（同比+3.88pct），预计主因受抖音等电商投流、 加速终端用户品牌形象触达影响，管理/研发费用率 4.73%/3.08% （同比-0.13pct/-0.03pct），净利率 10.33%（+0.06pct）。 业绩简评 4 月 21 日公司披露 24 年业绩及 25Q1 季报，24 年收入 15.6 亿元 （同比+13.4%），归母净利 1.61 亿元（同比+14.07%），净利率 10.33%（同比+0.06pct）。24Q4 收入 5.07 亿元（同比+39.12%）， 归母净利 0.43 亿元（同比+28.58%），25Q1 收入 4.3 亿元（同比 +19.36%），归母净利 0.43 亿元（同比+15.64%）。 经营分析 把握抖音红利，大单品快速放量带动增速加快、品牌势能提升。 1）分产品：24 年成人牙膏/成人牙刷/儿童牙膏/儿童牙刷/电动 牙刷/口腔医疗与美容护理产品营收 12.47/1.61/0.72/0.3/0.1/0.3 ...

Core Viewpoint - The company, Chongqing Dengkang Oral Care Products Co., Ltd., has released its 2024 annual report, highlighting its financial performance, operational strategies, and future development plans. Company Overview - The company is transitioning from a traditional manufacturing entity to a comprehensive solution provider, driven by innovations in biotechnology, artificial intelligence, cloud computing, big data, 5G, and the Internet of Things [4][12]. - The company emphasizes a dual-driven growth model combining organic growth and external expansion [4]. Financial Performance - For the year 2024, the company achieved a consolidated revenue of CNY 1,560,070,850.25, representing a year-on-year increase of 13.40% [34]. - The net profit attributable to shareholders was CNY 161,179,433.51, reflecting a growth of 14.07% compared to the previous year [34]. Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of CNY 7.50 per 10 shares, totaling CNY 129,130,350.00, with no bonus shares issued [24][25]. Research and Development - The company adopts a "marketing + R&D" dual-driven development strategy, focusing on market needs and maintaining a technology innovation system [5][7]. - It has established a collaborative innovation ecosystem with various universities and research institutions to enhance its technological capabilities [8]. Sales and Marketing Strategy - The company has developed a marketing network that includes distribution, direct supply, and e-commerce models, effectively reaching consumers across various channels [11][12]. - The strategy aims to enhance brand awareness and market penetration, supporting the growth of the oral health industry [12]. Governance and Compliance - The board of directors has ensured compliance with relevant laws and regulations, maintaining transparency and accountability in its operations [19][21]. - The company has also approved the continuation of its auditing firm, Xinyong Zhonghe, for the 2025 fiscal year [30].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001328证券简称：登康口腔公告编号：2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 （2022年修订）》（证监会公告〔2022〕15号）和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作（2023年12月修订）》（深证上〔2023〕1145号）的规 定，将本公司募集资金2024年度存放与使用情况专项说明如下： 一、 募集资金基本情况 （一） 实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意重庆登康口腔护理用品股份有限公司首次公开发行股票注册的 批复》（证监许可〔2023〕585号），本公司由主承销商中信建投证券股份有限公司采用网下向符合条 件的投资者询价配售及网上向持有深圳市场非限售A股股份和非限售存托凭证市值的社会公众投资者定 价发行相结合的方式，向社会公众公开发行人民币普通股（A股）股票4,304.35万股，发行价为每股人 民 ...

经过多年的培育与发展，2022年～2024年，公司核心品牌"冷酸灵"在抗敏感细分领域的线下零售市场份 额占比分别为61.74%、64.41%和64.72%，持续占据领导地位。儿童品类通过产品创新和热门IP，持续 提升市场份额，2024年线下零售市场，冷酸灵贝乐乐儿童牙膏进位行业第三，儿童牙刷跻身行业第一。 同时，公司积极投入并着力发展电动口腔护理产品市场拓展，先后推出"登康""冷酸灵""贝乐乐"电动牙 刷及冲牙器等电动口腔产品，为消费者提供更丰富的口腔护理选择。同时，公司逐步丰富了牙齿脱敏 剂、口腔抑菌膏、口腔抑菌护理液、美白牙贴、牙线棒、正畸牙刷、正畸保持器清洁片等细分子品类， 公司主营业务从口腔清洁基础护理向口腔医疗、口腔美容等领域快速延伸，2024年口腔医疗与美容护理 产品营业收入同比增长35.45%，为全面进入口腔大健康产业奠定坚实基础。 此外，公司注重数字化转型，通过智能化、数字化的管理提升了整体运营效率，以应对日益激烈的市场 竞争。 同日，登康口腔发布一季报，今年1月～3月，公司实现营业总收入4.30亿元，同比增长19.36%，归母净 利润4315.26万元，同比增长15.64%，业绩持续稳健增长 ...

证券代码：001328 证券简称：登康口腔 公告编号：2025-015 重庆登康口腔护理用品股份有限公司 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 重庆登康口腔护理用品股份有限公司（以下简称"公司"）根据中华人民共和国 财政部（以下简称"财政部"）发布的《企业会计准则应用指南汇编2024》《关于印 发<企业会计准则解释第18号>的通知》（财会〔2024〕24号，以下简称"《准则解释 第18号》"）要求变更会计政策，本次会计政策变更无需提交公司董事会和股东会审 议，不会对公司当期的财务状况、经营成果和现金流量产生重大影响。现将本次会计 政策变更的具体情况公告如下： 一、会计政策变更情况概述 （一）会计政策变更原因及适用日期 2024年，财政部发布了《企业会计准则应用指南汇编2024》《准则解释第18 号》，规定对不属于单项履约义务的保证类质量保证产生的预计负债，应当按确定的 金额计入"主营业务成本"和"其他业务成本"，不再计入"销售费用"。公司自 2024年1月1日起执行上述会计政策，将保证类质保费用计入营业成本。 （二）变更前采用 ...

2024 年度独立董事述职报告 （靳景玉） 根据《中华人民共和国公司法》《上市公司治理准则》《上市公司独立董事 管理办法》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规 范运作》等有关法律法规要求，及《公司章程》《独立董事工作细则》相关条款 要求，本人作为重庆登康口腔护理用品股份有限公司（以下简称"公司"）第七 届董事会的独立董事，忠实勤勉履行职责，积极出席相关会议，认真审议董事会 各项议案，充分发挥独立董事的作用，维护全体股东的合法权益和公司整体利益。 现将本人在 2024 年任职期间的履职情况汇报如下： 一、独立董事基本情况 （一）个人简历 靳景玉先生，1965 年生，中国国籍，无境外永久居留权，管理科学与工程专 业管理学博士。2000 年 3 月至 2017 年 7 月历任重庆商学院金融投资系副主任， 重庆工商大学金融学副教授、教授，重庆金融产品交易所有限责任公司独立董事； 兼任西南合成制药股份公司（股票代码：000788.SZ）董事及董事会秘书、重庆 天地药业有限公司董事长、重庆万里蓄电池股份有限公司（现称：重庆万里新能 源股份有限公司，股票代码：600847.SH)董事及董事会秘书 ...